Yehuda Handelsman to Aged, 80 and over
This is a "connection" page, showing publications Yehuda Handelsman has written about Aged, 80 and over.
Connection Strength
0.801
-
Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine. Adv Ther. 2019 12; 36(12):3321-3339.
Score: 0.144
-
Cardiovascular events and death after myocardial infarction or ischemic stroke in an older Medicare population. Clin Cardiol. 2019 Mar; 42(3):391-399.
Score: 0.138
-
Efficacy and safety of insulin glargine/lixisenatide (iGlarLixi) fixed-ratio combination in older adults with type 2 diabetes. J Diabetes Complications. 2019 03; 33(3):236-242.
Score: 0.135
-
How does CKD affect HbA1c? J Diabetes. 2018 Apr; 10(4):270.
Score: 0.127
-
Diabetes treatment over age 65: Is worse control really better? J Diabetes. 2017 May; 9(5):428-430.
Score: 0.120
-
POTENTIAL PLACE OF SGLT2 INHIBITORS IN TREATMENT PARADIGMS FOR TYPE 2 DIABETES MELLITUS. Endocr Pract. 2015 Sep; 21(9):1054-65.
Score: 0.107
-
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial. Lancet Diabetes Endocrinol. 2017 12; 5(12):941-950.
Score: 0.031